Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Second, repeated switching was IBS-driven, with slight modulation by patient-related factors and access
Researchers found that the GLP-1 group did not have higher rates of gestational diabetes, severe maternal morbidity, or other adverse maternal outcomes, suggesting that the medication may have helped mitigate elevated risk factors
Lehmann D (1987)
Although it is challenging to develop individualized therapeutic regimens, personalized medicine, such as genetics and biomarker testing, can be used to tailor therapies to patients specific conditions, thereby improving the safety and efficacy of treatments (Sugandh et al., 2023)
US$ 28.35
US$ 25.97
US$ 25.68
US$ 26.38
US$ 23.48
US$ 24.47
